Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBB.1.5.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBB.1.5.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EG.2.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EG.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.2.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FK.1.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FK.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FK.1.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FK.1.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FT.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-1540.71France
FT.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FT.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
FT.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBF.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBF.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-5579.54China
XBF.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GJ.1.2.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GJ.1.2.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GJ.1.2.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.25ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.25NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAGORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAGENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAGENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAGNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.8ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.8ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.8NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.9.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.9.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used